Cresset Asset Management, LLC Ginkgo Bioworks Holdings, Inc. Transaction History

Cresset Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.28 - $1.16 $52,781 - $218,666	-188,506 Reduced 48.67%	198,800 $65,000
Q1 2024 May 15, 2024	BUY	$1.06 - $1.67 $85,302 - $134,391	80,474 Added 26.23%	387,306 $449,000
Q4 2023 Feb 14, 2024	BUY	$1.26 - $1.79 $16,977 - $24,118	13,474 Added 4.59%	306,832 $518,000
Q3 2023 Nov 14, 2023	BUY	$1.61 - $2.54 $34,381 - $54,241	21,355 Added 7.85%	293,358 $530,000
Q2 2023 Aug 14, 2023	BUY	$1.14 - $1.95 $273,048 - $467,056	239,516 Added 737.27%	272,003 $505,000
Q1 2023 May 12, 2023	SELL	$1.2 - $2.19 $528 - $963	-440 Reduced 1.34%	32,487 $43,000
Q4 2022 Feb 14, 2023	SELL	$1.63 - $3.52 $9,062 - $19,571	-5,560 Reduced 14.45%	32,927 $55,000
Q3 2022 Nov 14, 2022	BUY	$0.73 - $3.74 $18,250 - $93,500	25,000 Added 185.36%	38,487 $120,000
Q2 2022 Aug 15, 2022	BUY	$2.2 - $4.2 $29,671 - $56,645	13,487 New	13,487 $32,000

48.4M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $9.25B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cresset Asset Management, LLC with notifications on news.